IOVA
Iovance Biotherapeutics, Inc.
Set alert
8.48 USD -1.08 -11.30%
8.27 Day range 9.17
1.81 52-week range 14.86
- YTD
- +210.62%
- 1 year
- +334.87%
- Open
- 9.15
- Prev close
- 9.56
- Mkt cap
- 3.84B
- Vol
- 31.20M
- Avg vol
- 17.06M
- EPS
- -0.69
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.27
- High
- 9.17
- Forward P/E
- -43.32
- Beta
- 0.76
- Short ratio
- 3.26
- Inst. own
- 70.71%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 11.38
- 200-d avg
- 5.81
- 1y target
- 14.40
1Y chart
Closing price and volume
Compare IOVA
Chart and line up IOVA against other symbols or a saved comparison set.
- IOVA Iovance Biotherapeutics, Inc.
8.48
-1.08 -11.30%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | IOVA | SPY | QQQ |
|---|---|---|---|
| Last price | 8.48 | 755.72 | 690.49 |
| Change | -1.08 | -13.64 | -24.85 |
| Change % | -11.30% | -1.77% | -3.47% |
| Open | 9.15 | 761.38 | 697.13 |
| Day high | 9.17 | 761.46 | 698.63 |
| Day low | 8.27 | 750.36 | 683.45 |
| Previous close | 9.56 | 769.36 | 715.34 |
| Volume | 31.20M | 77.70M | 85.24M |
| Average volume | 17.06M | 41.22M | 34.57M |
| Market cap | 3.84B | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | -0.69 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 14.86 | 779.09 | 759.66 |
| 52-week low | 1.81 | 631.97 | 558.28 |
| 1-week return | -39.82% | -0.559233% | -1.97% |
| 1-month return | -42.78% | -0.906075% | -6.66% |
| 3-month return | +80.81% | +1.89% | +1.02% |
| 6-month return | +152.38% | +5.16% | +3.41% |
| Year-to-date return | +210.62% | +10.82% | +12.40% |
| 1-year return | +334.87% | +11.16% | +10.29% |
| 2-year return | -18.77% | +32.90% | +42.71% |
| 50-day moving average | 11.38 | 767.63 | 725.41 |
| 200-day moving average | 5.81 | 728.53 | 679.17 |
| Target price | 14.40 | — | — |
| Beta | 0.757 | 0.00 | 0.00 |
| Short ratio | 3.26 | — | — |
| Institutional ownership | 70.71% | — | — |